A recent study suggested that tumor-suppressor activity of adiponectin in human PC may be also associated to modulation of the β-Catenin pathway, since downregulation of cellular β-catenin levels through the Akt/GSK3-β pathway was found in PC lines treated with adiponectin [43]. The gene discussed is ADIPOQ; the disease is pachyonychia congenita.